Insulin Receptor Substrate-2 Proteasomal Degradation Mediated by a Mammalian Target of Rapamycin (mTOR)-induced Negative Feedback Down-regulates Protein Kinase B-mediated Signaling Pathway in β-Cells

Regulation of insulin receptor substrate (IRS)-2 expression is critical to β-cell survival, but the mechanisms that control this are complex and undefined. Here in pancreatic β-cells (INS-1), chronic exposure (>8 h) to 15 mm glucose and/or 5 nm IGF-1, increased Ser/Thr phosphorylation of IRS-2, w...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of biological chemistry Vol. 280; no. 3; pp. 2282 - 2293
Main Authors Briaud, Isabelle, Dickson, Lorna M., Lingohr, Melissa K., McCuaig, Jill F., Lawrence, John C., Rhodes, Christopher J.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 21.01.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Regulation of insulin receptor substrate (IRS)-2 expression is critical to β-cell survival, but the mechanisms that control this are complex and undefined. Here in pancreatic β-cells (INS-1), chronic exposure (>8 h) to 15 mm glucose and/or 5 nm IGF-1, increased Ser/Thr phosphorylation of IRS-2, which correlated with decreased IRS-2 levels. This glucose/IGF-1-induced decrease in IRS-2 levels was prevented by the proteasomal inhibitor, lactacystin. In addition, the glucose/IGF-1-induced increase in Ser/Thr phosphorylation of IRS-2 and the subsequent decrease in INS-1 cell IRS-2 protein levels was thwarted by the mammalian target of rapamycin(mTOR) inhibitor, rapamycin. Moreover, adenoviral-mediated expression of constitutively active mTOR (mTORΔ) further increased glucose/IGF-1-induced Ser/Thr phosphorylation of IRS-2 and decreased IRS-2 protein levels, whereas adenoviral-mediated expression of “kinase-dead” mTOR (mTOR-KD) conversely reduced Ser/Thr phosphorylation of IRS-2 and maintained IRS-2 protein levels. In adenoviral-infected β-cells expressing mTORΔ, the decrease in IRS-2 protein levels was also prevented by rapamycin or lactacystin, further indicating a proteasomal mediated degradation of IRS-2 mediated via mTOR-induced Ser/Thr phosphorylation of IRS-2. Finally, we found that chronic activation of mTOR leading to decreased levels of IRS-2 in INS-1 cells led to a significant decrease in PKB activation and consequently increased β-cell apoptosis. Thus, chronic activation of mTOR by glucose (and/or IGF-1) in β-cells leads to increased Ser/Thr phosphorylation of IRS-2 that targets it for proteasomal degradation, resulting in decreased IRS-2 expression and increased β-cell apoptosis. This may be a contributing mechanism as to how β-cell mass is decreased by chronic hyperglycemia in the pathogenesis of type-2 diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9258
1083-351X
DOI:10.1074/jbc.M412179200